Access to [6.4.0]Carbocyclic Systems by Tandem Metathesis of Dienynes. A Step toward the Synthesis of a PreD3-D3 Transition State Analogue

Organic Letters

Volumn 3, Issue 10, 2001, Pages 1483-1486

  Codesido, Eva M ^a   Castedo, Luis ^a   Granja, Juan R ^a  

^a UNIVERSITY OF SANTIAGO DE COMPOSTELA   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

COLECALCIFEROL; DRUG DERIVATIVE; HAPTEN; PREVITAMIN D(3);

ARTICLE; CHEMISTRY; PHOTOCHEMISTRY; STRUCTURE ACTIVITY RELATION; SYNTHESIS;

CHOLECALCIFEROL; HAPTENS; PHOTOCHEMISTRY; STRUCTURE-ACTIVITY RELATIONSHIP;

EID: 0035902234     PISSN: 15237060     EISSN: None     Source Type: Journal    
DOI: 10.1021/ol0158011     Document Type: Article

References (40)

1. Henry, H. L.; Norman, A. W. Metabolism of Vitamin D. In Disorders of Bone and Mineral Metabolism; Coe, F. L., Favus, M. J., Eds.; Raven Press: New York, 1991; pp 149-162.
2. (a) Bouillon, R.; Okamura, W. H.; Norman, A. W. Endocr. Rev. 1995, 16, 200-257.
3. (b) Vitamin D: Chemistry, Biology and Clinical Applications of the Steroid Hormone; Norman, A. W., Bouillon, R., Thomasset, M., Eds; Vitamin D Workshop, Inc.: Riverside, CA, 1997.
4. 3 equilibrium in biological activity, see: (a) Norman, A. W.; Okamura, W. H.; Farach-Carson, M. C.; Allewaert, K.; Branisteanu, D.; Nemere, I.; Muralidharan, K. R. Bouillon, R. J. Biol. Chem. 1993, 268, 13811-13819.
5. (b) Okamura, W. H.; Midland, M. M.; Norman, A. W.; Hammond, M. W.; Dormanen, M. C.; Nemere, I. Ann. N.Y. Acad. Sci. 1995, 761, 344-348.
6. (a) Havinga, E. Experientia 1973, 29, 1181-1192.
7. (b) Dauben, W. G.; Funhoff, D. J. H. J. Org. Chem. 1988, 53, 5070-5075.
8. Okamura, W. H.; Midland, M. M.; Hammond, M. W.; Rahman, N. A.; Dormanen, M. C.; Nemere, I.; Norman, A. W. J. Steroid Biochem. Mol. Biol. 1995, 53, 603-613.
9. (a) Tian, X. Q.; Chen, T. C.; Matsuoka, L. Y.; Wortsman, J.; Holick, M. F. J. Biol. Chem. 1993, 268, 14888-14892.
10. (b) Tian, X. Q.; Holick, M. F. J. Biol. Chem. 1995, 270, 8706-8711.
11. (c) Tian, X. Q.; Holick, M. F. J. Biol. Chem. 1999, 274, 4174-4179.
12. Schlatmann, J. L. M. A.; Pot, J.; Havinga, E. Rec. Trav. Chim. Pays-Bas 1964, 83, 1173-1184.
13. Catalytic antibody strategy is a powerful method for the design of enzymes that achieve transformations that are rare or do not occur in nature; see: (a) Schultz, P. G.: Lerner, R. A. Science 1995, 269, 1835-1842.
14. (b) Wentworth, P.; Janda, K. D. Curr. Opin. Chem. Biol. 1998, 2, 138-144.
15. (c) Hilvert, D. Top. Stereochem. 1999, 22, 83-135.
16. (a) Sarandeses, L. A.; Mascareñas, J. L.; Castedo, L.; Mouriño, A. Tetrahedron Lett. 1992, 33, 5445-5448.
17. (b) Díaz, M.; Ferrero, M.; Férnandez, S.; Gotor, V. J. Org. Chem. 2000, 65, 5647-5652.
18. (a) For reviews on metathesis, see: Fürstner, A. Angew. Chem., Int. Ed. 2000, 39, 3012-3043.
19. (b) Chang, S.; Grubbs, R. H. Tetrahedron 1998, 54, 4413-4450.
20. (c) For a recent view on the synthesis of medium-sized rings by RCM, see: Maier, M. E. Angew. Chem., Int. Ed. 2000, 39, 2073-2077.
21. (d) For a more general review on the synthesis of medium-sized rings, see: Yet, L. Chem. Rev. 2000, 100, 2963-3007.
22. For convenience, steroid numbering is used.
23. For enantioselective synthesis of 4, see: Codesido, E. M.; Cid, M. M.; Castedo, L.; Mouriño, A.; Granja, J. R. Tetrahedron Lett. 2000, 41, 5861-5864.
24. 3; see: Mascareñas, J. L.; Sarandeses, L.; Castedo, L.; Mouriño, A. Tetrahedron 1991, 47, 3485-3498.
25. Bromide 5 was prepared in 81% yield by treatment of alcohol 4 with triphenylphosphine and carbon tetrabromide in dichloromethane.
26. Scholl, M.; Ding, S.; Lee, C. W.; Grubbs, R. H. Org. Lett. 1999, 1, 953-956.
27. (a) Fürstner, A.; Langemann, K. J. Am. Chem. Soc. 1997, 119, 9130-9136.
28. (b) Crimmins, M. T.; Choy, A. L. J. Am. Chem. Soc. 1999, 121, 5653-5660.
29. (c) Paquette, L. A.; Tae, J.; Arrington, M. P.; Sadoun, A. H. J. Am. Chem. Soc 2000, 122, 2742-2748.
30. (a) Miller, S. J.; Kim, S.-H.; Chen, Z.-R.; Grubbs, R. H. J. Am. Chem. Soc. 1995, 117, 2108-2109.
31. (b) For an example of tricyclic system formation using a cis-diene, see: Holt, D. J.; Barker, W. D.; Jenkins, P. R.; Davies, D. L.; Garrat, S.; Fawcet, J.; Russell, D. R.; Ghosh, S. Angew. Chem., Int. Ed. 1998, 37, 3298-3300.
32. (c) 1, 2-cis disubstituted cyclopentane derivatives were also worse substrates than the trans dienes: Paquete, L. A.; Mendez-Andino, J. Tetrahedron Lett. 1999, 40, 4301-4304.
33. (d) Fürstner, A.; Langemann, K. J. Org. Chem. 1996, 61, 8746-9749.
34. (a) Kim, S.-H.; Bowden, N.; Grubbs, R. H. J. Am. Chem. Soc. 1994, 116, 10801-10802.
35. (b) Kim, S.-H.; Zuercher, W. J.; Bowden, N. B.; Grubbs, R. H. J. Org. Chem. 1996, 61, 1073-1081.
36. (c) Zuercher, W. J.; Scholl, M.; Grubbs, R. H. J. Org. Chem. 1998, 63, 4291-4298.
37. (d) Fürstner, A.; Liebl, M.; Hill, A. F.; Wilton-Ely, J. D. E. T. Chem. Commun. 1999, 601-602.
38. For recent eight-membered heterocycle ring formation using enyne metathesis, see: Mori, M.; Kitamura, T.; Sakakibara, N.; Sato, Y. Org. Lett. 2000, 2, 543-545.
39. Harris, G. D.; Herr, R. J.; Weinreb, S. M. J. Org. Chem. 1993, 58, 5452-5464.
40. These reaction conditions were kindly suggested by Prof. Claudio Palomo (Univ. País Vasco), who developed them in his studies of asymmetric alkylations.